{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:42:07Z","timestamp":1793464927233,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ymthe.2024.03.022","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T11:05:33Z","timestamp":1712055933000},"page":"1266-1283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Carrier-free mRNA vaccine induces robust immunity against SARS-CoV-2 in mice and non-human primates without systemic reactogenicity"],"prefix":"10.1016","volume":"32","author":[{"given":"Saed","family":"Abbasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Matsui-Masai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akimasa","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theofilus A.","family":"Tockary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Mochida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Akinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michinori","family":"Kohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8726-0478","authenticated-orcid":false,"given":"Satoshi","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.03.022_bib1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2024.03.022_bib2","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/d41586-021-03686-x","article-title":"How COVID vaccines shaped 2021 in eight powerful charts","volume":"600","author":"Mallapaty","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.03.022_bib3","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2024.03.022_bib4","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.03.022_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.03.022_bib6","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2024.03.022_bib7","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3390\/pharmaceutics13050644","article-title":"Multifunctional Immunoadjuvants for Use in Minimalist Nucleic Acid Vaccines","volume":"13","author":"Abbasi","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ymthe.2024.03.022_bib8","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","article-title":"Innate immune mechanisms of mRNA vaccines","volume":"55","author":"Verbeke","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2024.03.022_bib9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.ymthe.2024.03.022_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","article-title":"Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines","volume":"15","author":"Hassett","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2024.03.022_bib11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41551-019-0378-3","article-title":"Visualization of early events in mRNA vaccine delivery in non-human primates via PET-CT and near-infrared imaging","volume":"3","author":"Lindsay","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2024.03.022_bib12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11095-022-03166-5","article-title":"Biodistribution and Non-linear Gene Expression of mRNA LNPs Affected by Delivery Route and Particle Size","volume":"39","author":"Di","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ymthe.2024.03.022_bib13","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","article-title":"Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting","volume":"385","author":"Barda","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.03.022_bib14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41392-021-00634-z","article-title":"A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity","volume":"6","author":"Yang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2024.03.022_bib15","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.ymthe.2023.06.017","article-title":"A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation","volume":"31","author":"Kimura","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.03.022_bib16","doi-asserted-by":"crossref","first-page":"e210804","DOI":"10.1001\/jamahealthforum.2021.0804","article-title":"Fear of Adverse Effects and COVID-19 Vaccine Hesitancy: Recommendations of the Treatment Expectation Expert Group","volume":"2","author":"Rief","year":"2021","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.ymthe.2024.03.022_bib17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/vaccines7030096","article-title":"Immunogenicity and Protection Efficacy of a Naked Self-Replicating mRNA-Based Zika Virus Vaccine","volume":"7","author":"Zhong","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2024.03.022_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106335","article-title":"Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunity","volume":"26","author":"Amano","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.ymthe.2024.03.022_bib19","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.03.022_bib20","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102595118","article-title":"Transdermal vaccination via 3D-printed microneedles induces potent humoral and cellular immunity","volume":"118","author":"Caudill","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.03.022_bib21","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3390\/vaccines9121375","article-title":"Immunogenicity and Safety of an Intradermal BNT162b2 mRNA Vaccine Booster after Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthy Population","volume":"9","author":"Intapiboon","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2024.03.022_bib22","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.7326\/M22-2089","article-title":"Safety and Immunogenicity of Intradermal Fractional Dose Administration of the mRNA-1273 Vaccine: A Proof-of-Concept Study","volume":"175","author":"Roozen","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ymthe.2024.03.022_bib23","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.3390\/vaccines10091494","article-title":"T-Cell Responses Induced by an Intradermal BNT162b2 mRNA Vaccine Booster Following Primary Vaccination with Inactivated SARS-CoV-2 Vaccine","volume":"10","author":"Sophonmanee","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2024.03.022_bib24","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1016\/j.vaccine.2008.03.095","article-title":"Intradermal vaccine delivery: will new delivery systems transform vaccine administration?","volume":"26","author":"Lambert","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2024.03.022_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1479-0556-4-4","article-title":"Characterization of the ribonuclease activity on the skin surface","volume":"4","author":"Probst","year":"2006","journal-title":"Genet. Vaccin. Ther."},{"key":"10.1016\/j.ymthe.2024.03.022_bib26","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1007\/s00018-004-4255-0","article-title":"Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines","volume":"61","author":"Carralot","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2024.03.022_bib27","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00262-016-1869-7","article-title":"Uptake of synthetic naked RNA by skin-resident dendritic cells via macropinocytosis allows antigen expression and induction of T-cell responses in mice","volume":"65","author":"Selmi","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ymthe.2024.03.022_bib28","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.xphs.2019.02.021","article-title":"Development of Pyro-Drive Jet Injector With Controllable Jet Pressure","volume":"108","author":"Miyazaki","year":"2019","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.ymthe.2024.03.022_bib29","doi-asserted-by":"crossref","first-page":"9094","DOI":"10.3390\/ijms24109094","article-title":"A Promising Needle-Free Pyro-Drive Jet Injector for Augmentation of Immunity by Intradermal Injection as a Physical Adjuvant","volume":"24","author":"Sonoda","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2024.03.022_bib30","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ymthe.2017.03.035","article-title":"Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses","volume":"25","author":"Bahl","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.03.022_bib31","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/j.ymthe.2021.05.011","article-title":"Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T\u00a0cells against a lethal viral infection","volume":"29","author":"Knudson","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.03.022_bib32","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.immuni.2021.06.018","article-title":"COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge","volume":"54","author":"DiPiazza","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2024.03.022_bib33","doi-asserted-by":"crossref","first-page":"9031","DOI":"10.1158\/0008-5472.CAN-10-0699","article-title":"Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity","volume":"70","author":"Kreiter","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2024.03.022_bib34","article-title":"Early circulating strain of SARS-CoV-2 causes severe pneumonia distinct from that caused by variants of concern","author":"Matsumoto","year":"2022","journal-title":"Res. Square"},{"key":"10.1016\/j.ymthe.2024.03.022_bib35","article-title":"Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B","volume":"8","author":"Liu","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2024.03.022_bib36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03275-y","article-title":"BNT162b vaccines protect rhesus macaques from SARS-CoV-2","volume":"592","author":"Vogel","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.03.022_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq1945","article-title":"Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models","volume":"14","author":"Hajnik","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2024.03.022_bib38","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s41587-020-0631-z","article-title":"A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction","volume":"38","author":"Tan","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.03.022_bib39","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/sj.gt.3302964","article-title":"Spontaneous cellular uptake of exogenous messenger RNA in\u00a0vivo is nucleic acid-specific, saturable and ion dependent","volume":"14","author":"Probst","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2024.03.022_bib40","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.cell.2009.01.019","article-title":"The many pathways of RNA degradation","volume":"136","author":"Houseley","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2024.03.022_bib41","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3390\/v14030540","article-title":"Antibodies to Crucial Epitopes on HSV-2 Glycoprotein D as a Guide to Dosing an mRNA Genital Herpes Vaccine","volume":"14","author":"Hook","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2024.03.022_bib42","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/cid\/ciab707","article-title":"Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model","volume":"74","author":"Li","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ymthe.2024.03.022_bib43","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/j.ymthe.2017.08.006","article-title":"Efficient Targeting and Activation of Antigen-Presenting Cells In\u00a0Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques","volume":"25","author":"Liang","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.03.022_bib44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-022-04527-1","article-title":"Germinal centre-driven maturation of B cell response to mRNA vaccination","volume":"604","author":"Kim","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.03.022_bib45","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.20171450","article-title":"Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses","volume":"215","author":"Pardi","year":"2018","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2024.03.022_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010255","article-title":"Langerhans cells and cDC1s play redundant roles in mRNA-LNP induced protective anti-influenza and anti-SARS-CoV-2 immune responses","volume":"18","author":"Ndeupen","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ymthe.2024.03.022_bib47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jconrel.2021.08.029","article-title":"Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines","volume":"338","author":"Blakney","year":"2021","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.ymthe.2024.03.022_bib48","doi-asserted-by":"crossref","first-page":"12406","DOI":"10.1096\/fj.202000848R","article-title":"Immunological dynamics after subcutaneous immunization with a squalene-based oil-in-water adjuvant","volume":"34","author":"Schetters","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2024.03.022_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104743","article-title":"Differences in SARS-CoV-2 specific humoral and cellular immune responses after contralateral and ipsilateral COVID-19 vaccination","volume":"95","author":"Ziegler","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2024.03.022_bib50","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T\u00a0cell responses","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.03.022_bib51","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrd2076","article-title":"Current status and future prospects of needle-free liquid jet injectors","volume":"5","author":"Mitragotri","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2024.03.022_bib52","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.medengphy.2011.12.010","article-title":"Needle-free jet injection using real-time controlled linear Lorentz-force actuators","volume":"34","author":"Taberner","year":"2012","journal-title":"Med. Eng. Phys."},{"key":"10.1016\/j.ymthe.2024.03.022_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15830-7","article-title":"Allometric scaling of skin thickness, elasticity, viscoelasticity to mass for micro-medical device translation: from mice, rats, rabbits, pigs to humans","volume":"7","author":"Wei","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2024.03.022_bib54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1208\/s12249-019-1564-z","article-title":"Stable Immune Response Induced by Intradermal DNA Vaccination by a Novel Needleless Pyro-Drive Jet Injector","volume":"21","author":"Chang","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ymthe.2024.03.022_bib55","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.xphs.2020.11.020","article-title":"Potent Intradermal Gene Expression of Naked Plasmid DNA in Pig Skin Following Pyro-drive Jet Injection","volume":"110","author":"Miyazaki","year":"2021","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.ymthe.2024.03.022_bib56","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1017\/S0033291721002609","article-title":"Injection fears and COVID-19 vaccine hesitancy","volume":"53","author":"Freeman","year":"2023","journal-title":"Psychol. Med."},{"key":"10.1016\/j.ymthe.2024.03.022_bib57","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3390\/vaccines10091427","article-title":"Phase I Study to Assess the Safety and Immunogenicity of an Intradermal COVID-19 DNA Vaccine Administered Using a Pyro-Drive Jet Injector in Healthy Adults","volume":"10","author":"Nakagami","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2024.03.022_bib58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1423-0127-21-3","article-title":"Shear-induced endothelial mechanotransduction: the interplay between reactive oxygen species (ROS) and nitric oxide (NO) and the pathophysiological implications","volume":"21","author":"Hsieh","year":"2014","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.ymthe.2024.03.022_bib59","article-title":"Low shear stress induced HMGB1 translocation and release via PECAM-1\/PARP-1 pathway to induce inflammation response","volume":"10","author":"Qin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2024.03.022_bib60","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1038\/s41598-017-04547-2","article-title":"Electroporation as a vaccine delivery system and a natural adjuvant to intradermal administration of plasmid DNA in macaques","volume":"7","author":"Todorova","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2024.03.022_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.102070","article-title":"Intradermal DNA vaccine delivery using vacuum-controlled, needle-free electroporation","volume":"34","author":"Generotti","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2024.03.022_bib62","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1038\/jid.2014.174","article-title":"Colocalization of cell death with antigen deposition in skin enhances vaccine immunogenicity","volume":"134","author":"Depelsenaire","year":"2014","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ymthe.2024.03.022_bib63","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1248\/bpb.b16-00113","article-title":"Application of Microneedles to Skin Induces Activation of Epidermal Langerhans Cells and Dermal Dendritic Cells in Mice","volume":"39","author":"Takeuchi","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ymthe.2024.03.022_bib64","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41541-022-00581-y","article-title":"A novel intradermal tattoo-based injection device enhances the immunogenicity of plasmid DNA vaccines","volume":"7","author":"Gomez","year":"2022","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2024.03.022_bib65","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1096\/fj.201902164R","article-title":"Laser adjuvant for vaccination","volume":"34","author":"Kashiwagi","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2024.03.022_bib66","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/nat.2018.0734","article-title":"MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-Destruct","volume":"28","author":"Jain","year":"2018","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.ymthe.2024.03.022_bib67","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.biomaterials.2015.12.031","article-title":"Systemic delivery of messenger RNA for the treatment of pancreatic cancer using polyplex nanomicelles with a cholesterol moiety","volume":"82","author":"Uchida","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.ymthe.2024.03.022_bib68","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jhep.2022.03.040","article-title":"SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis","volume":"77","author":"Boettler","year":"2022","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2024.03.022_bib69","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jhep.2021.09.031","article-title":"Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed","volume":"76","author":"Zin Tun","year":"2022","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2024.03.022_bib70","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3390\/vaccines10060866","article-title":"What Should We Do after the COVID-19 Vaccination? Vaccine-Associated Diseases and Precautionary Measures against Adverse Reactions","volume":"10","author":"Awaya","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2024.03.022_bib71","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3390\/vaccines11050934","article-title":"Graves\u2019 Disease after mRNA COVID-19 Vaccination, with the Presence of Autoimmune Antibodies Even One Year Later","volume":"11","author":"Nakamura","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2024.03.022_bib72","doi-asserted-by":"crossref","first-page":"14022","DOI":"10.1021\/acsnano.1c05922","article-title":"Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies","volume":"15","author":"Chen","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.ymthe.2024.03.022_bib73","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.03.022_bib74","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg2783","article-title":"Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers","volume":"15","author":"Schmidt","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2024.03.022_bib75","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jaci.2009.06.036","article-title":"Immunize and disappear-safety-optimized mRNA vaccination with a panel of 29 allergens","volume":"124","author":"Roesler","year":"2009","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.ymthe.2024.03.022_bib76","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2144\/000112593","article-title":"Long-term storage of DNA-free RNA for use in vaccine studies","volume":"43","author":"Jones","year":"2007","journal-title":"Biotechniques"},{"key":"10.1016\/j.ymthe.2024.03.022_bib77","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.1021\/acs.molpharmaceut.3c00956","article-title":"Investigations into mRNA Lipid Nanoparticles Shelf-Life Stability under Nonfrozen Conditions","volume":"20","author":"Reinhart","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ymthe.2024.03.022_bib78","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1021\/acscentsci.1c00197","article-title":"Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines","volume":"7","author":"Nance","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ymthe.2024.03.022_bib79","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","article-title":"An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow","volume":"223","author":"Lutz","year":"1999","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.ymthe.2024.03.022_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.967019","volume":"13","author":"Ishigaki","year":"2022","journal-title":"Front. Microbiol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624001631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624001631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T13:48:40Z","timestamp":1720446520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624001631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":80,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1525001624001631"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.03.022","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carrier-free mRNA vaccine induces robust immunity against SARS-CoV-2 in mice and non-human primates without systemic reactogenicity","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s).","name":"copyright","label":"Copyright"}]}}